Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection

Patients with Hantavirus-caused epidemic hemorrhagic fever (EHF) are at risk of contracting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is currently no validated EHF/SARS-CoV-2 strategy. Several studies have recently shown Puerarin, a natural product, has potent anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Weizheng, Li, Xiushen, Wang, Hao, Nie, Kechao, Meng, Qingxue, He, Junli, Zheng, Chunfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161725/
https://www.ncbi.nlm.nih.gov/pubmed/35663983
http://dx.doi.org/10.3389/fimmu.2022.892350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161725/
https://www.ncbi.nlm.nih.gov/pubmed/35663983
http://dx.doi.org/10.3389/fimmu.2022.892350

Ejemplares similares